SCHEMBL12401801

SCHEMBL12401801

CCOc1c(C)cc(C(C)(C)C)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
HTR1D P28221 2/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.40
GLA P06280 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTR1B P28222 1/20 0.38
ESR1 P03372 1/20 0.38
TSHR P16473 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ELANE P08246 1/20 0.37
CD69 Q07108 1/20 0.37
RARG P13631 1/20 0.36
RXRA P19793 1/20 0.36
PPARG P37231 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29201869 0.88 TSHR (0.41) POLBHTR1DKDM4EALDH1A1GAA
SCHEMBL13996167 0.86 ALDH1A1 (0.40) KDM4EALDH1A1GLAMAPTHPGD
SCHEMBL19919480 0.82 RXRA (0.36) POLBHTR1DKDM4EALDH1A1GLA
SCHEMBL16865668 0.81 MAPT (0.38) KDM4EALDH1A1GLAMAPTHPGD
SCHEMBL15187966 0.81 THRA (0.42) POLBHTR1DKDM4EALDH1A1MAPT
SCHEMBL7792776 0.80 RXRA (0.45) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL689186 0.78 MAPT (0.44) POLBHTR1DKDM4EALDH1A1MAPT
SCHEMBL12390575 0.78 PDE5A (0.37) POLBHTR1DALDH1A1MAPTNPSR1
SCHEMBL11586155 0.78 MAPT (0.43) KDM4EALDH1A1GLAMAPTHPGD
SCHEMBL15369554 0.78 THRA (0.50) KDM4EESR1TSHRRXRARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440706-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-14 US disclosed
US-8372873-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-02-12 US disclosed
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-28 US disclosed
US-7985762-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-07 US disclosed
US-7964624-B1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-21 US disclosed
US-20070179167-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES PRSS1, PRSS3, PRSS2 POLB 3945/4885HTR1D 2720/4885KDM4E 2603/4885
US-20070179167-A1 Inhibitors of serine proteases PRSS1, PRSS3, PRSS2 POLB 3945/4885HTR1D 2720/4885KDM4E 2603/4885
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES PRSS1, SPINT2, PRSS2 POLB 4161/4885HTR1D 2934/4885KDM4E 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.